Clinical Evidence

Explore the clinical evidence shaping the probiotics market today

Filter by Wellness Area

Therapeutical Areas to Clinical Evidence (desktop)
  • All
  • Weight Management
  • Gastrointestinal health
  • Pediatric health
  • Oral health
  • Cardiometabolic health
  • Immune health
  • Cognitive health
  • Skin health
  • Women's health
  • Eye health
Therapeutical Areas to Clinical Evidence (mobile)

Filter by Product

Products to Clinical Evidence (desktop)
  • All
  • KABP® Intensive G.I
  • KABP® Urinary Tract Support
  • KABP® Mature Immune Defense®
  • KABP® DENTALAC
  • LipiGO®
  • KABP® Digest
  • Brain (DR7)®
  • DR7
  • KABP® DENTISANI
  • KABP® Baby Colic
  • KABP® Vaginal Health Balance
  • KABP Cardio
  • KABP®-051
  • AB-Protears®
  • Kaneka Probiotics L.sakei proBio65 ®
  • KABP 21®
  • KABP® MENOPAUSE
Products to Clinical Evidence (mobile)
  • Oral administration of live and dead cells of Lactobacillus sakei proBio65 alleviated atopic dermatitis in children and adolescents: a randomized, double-blind, and placebo-controlled study

    2020

    Rather IA, et al

    Read
  • Effect of emollients containing vegetable-derived Lactobacillus in the treatment of atopic dermatitis symptoms: Split-body clinical trial

    2014

    Park SB, et al

    Read
  • Atopic dermatitis-mitigating effects of new Lactobacillus strain, Lactobacillus sakei probio 65 isolated from Kimchi

    2013

    Kim JY, et al

    Read
  • Immune-modulating characteristics of Lactobacillus sakei proBio65 isolated from Kimchi

    2011

    Lim J, et al

    Read
  • Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome

    2010

    Woo SI, et al

    Read